A combination of eyelid pressure patching and decellularized, dehydrated pure amniotic membrane basement membrane healed ...

DT-168 is a GeneTAC® small molecule, formulated as an eye drop, that is designed to selectively target the CTG repeat expansion in the TCF4 gene and reduce the expression of the mutant gene product ...

CARLSBAD, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic ...

Proceeds will go toward the Muscular Dystrophy Association. Parents will also need to fill out a waiver for kids before the event.

Sanofi has added to its rare disease pipeline by licensing an antibody-RNA conjugate (ARC) for facioscapulohumeral muscular dystrophy (FSHD), a genetic muscle disorder, from US biotech miRecule.

The FDA reviewer’s safety concerns concentrate on the DREAMM-2 trial, which showed that keratopathy – damage to the corneal epithelium – was seen in 71% of patients overall, with 44% of them ...

Over time, if left untreated, dry eye may lead to: eye pain corneal scarring vision loss Fortunately, managing your blood sugar and keeping it within a healthy range can lower your risk of dry eye ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

The new price transparency tool to compare reimbursement rates.